Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 2 hours ago
Takeda’s zasocitinib proves ‘top-notch’ for difficult-to-treat psoriasis in phase 3 update
about 2 hours ago
Takeda has unveiled more data from its phase 3 trials of zasocitinib...
Understanding Agentic AI in Clinical Development
about 9 hours ago
Earlier this year, my colleague Matt Harrington suggested that clinical leaders should...
Nobel Laureate Jennifer Doudna enters AI protein design arena
about 11 hours ago
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR...
Why Axiom hopes it’s ‘solved 2 major potholes’ that have hurt other stem cell biotechs
about 14 hours ago
When Axiom's stem cell therapy demonstrated a 0% mortality rate over two...
Racing Takeda, InnoCare reports TYK2 inhibitor win in phase 2 vitiligo trial
about 15 hours ago
A phase 2 trial of InnoCare Pharma’s TYK2 inhibitor soficitinib in nonsegmental...
Lilly buys AtaiBeckley for $2.8B upfront to challenge J&J for psychedelic mental health market
about 17 hours ago
Eli Lilly has struck a deal to buy AtaiBeckley for $2.8 billion...
Vogenx joins the IPO queue to fund phase 2-stage metabolic drug
about 19 hours ago
Vogenx has joined the growing queue for the Nasdaq, as the metabolic...
Braveheart aims for freedom with IPO to support Hengrui-licensed cardio asset
1 day ago
It appears Braveheart Bio isn’t going to let Big Pharma take its...
Big Pharma-backed AdvanCell, flush with $315M series D, ready to put radiotherapy pedal to the metal
1 day ago
Less than a month after locking down a lease for a new...
J&J axes eye disease gene therapy after key phase 2b readout
1 day ago
Johnson & Johnson has stopped development of an eye disease gene therapy...
J&J MedTech growth slows again in Q2 as Abiomed weighs on results
1 day ago
Johnson & Johnson’s MedTech business posted operational sales growth of 3.6% in...
Medtronic recalls catheter delivery system that may detach and cause death
1 day ago
Medtronic issued a voluntary recall of 102 lots of its Harmony delivery...